Frank Verwiel
CIK 1545794 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$425.6K
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$37.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTLA | Director | 35,148 | $12.11 | $425.6K | -$37.6K | 11 | 2026-06-10 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | — | — | — | $0 | 6 | 2020-01-29 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | $0 | 4 | 2018-05-15 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-12-16 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-10-01 | — | Disp (D) | −9,725 | -$719.6K | |
| 2013-06-03 | — | Grant (A) | — | $0 | |
| 2012-06-06 | — | Grant (A) | +2,500 | $25.2K | |
| 2012-04-13 | — | Grant (A) | +4,225 | $0 |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.